| CCK-8 | Cell counting kit |
| CDKs | Cyclin-dependent kinases |
| CML | Chronic myeloid leukemia |
| DLBCL | Diffuse large B-cell lymphoma |
| DMSO | Dimethyl sulfoxide |
| EGFR | Epidermal growth factor receptor |
| EMT | Epithelial–mesenchymal transition |
| IC50 | Half-maximal inhibitory concentration |
| MAPK | Mitogen-activated protein kinase |
| MMPs | Matrix metalloproteinases |
| NF-κB | Nuclear factor kappa B |
| PI3K | Phosphatidylinositol 3-kinase |
| R-CHOP | Rituximab-cyclophosphamide-hydroxydaunorubicin-oncovin-prednisone |
| PD-1/PD-L1 | Programmed death-1/programmed death-ligand 1 |
| TKIs | Tyrosine kinase inhibitors |
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.